instagram story viewer > #AlphaTau

#AlphaTau

Posts
Learn more about the ARYA-2 clinical trial for patients battling #hepatoblastoma at www.eurekaconnectme.com
Learn more about the ARYA-2 clinical trial for patients battling #hepatoblastoma at www.eurekaconnectme.com
For patients with severe Leukocyte Adhesion Deficiency Type I (LAD-I), treatment options have been limited. A new gene therapy may offer hope through the FDA’s accelerated approval pathway.
For patients with severe Leukocyte Adhesion Deficiency Type I (LAD-I), treatment options have been limited. A new gene therapy may offer hope through the FDA’s accelerated approval pathway.
If you know someone diagnosed with AFP+ pediatric liver cancer, such as hepatoblastoma, there are clinical trials available to them. Visit www.eurekaconnectme.com to learn more.
If you know someone diagnosed with AFP+ pediatric liver cancer, such as hepatoblastoma, there are clinical trials available to them. Visit www.eurekaconnectme.com to learn more.
🚀 AI Discovers New Cancer Drug. Harvard AI lab discovers new cancer drug targeting HER2. 96% effectiveness in trials. Heads to Phase 2 FDA review. Efficacy Rate: 96%. The AI space moves fast — stay ahead. 👇 #AI #Medicine #Healthcare #Biotech #TheAIChronicle #DailyAINews #AI #ArtificialIntelligence #Tech Source: https://harvard.edu/ai-cancer
🚀 AI Discovers New Cancer Drug. Harvard AI lab discovers new cancer drug targeting HER2. 96% effectiveness in trials. Heads to Phase 2 FDA review. Efficacy Rate: 96%. The AI space moves fast — stay ahead. 👇 #AI #Medicine #Healthcare #Biotech #TheAIChronicle #DailyAINews #AI #ArtificialIntelligence #Tech Source: https://harvard.edu/ai-cancer
How African startups use #AI to triage chest X‑rays, prioritize high-risk patients, save lives and augment scarce #radiologists — Insights by Philip Kiracofe, CEO at Startupbootcamp AfriTech . . . . . . . #Healthcare #Radiology #Cancer Medical
How African startups use #AI to triage chest X‑rays, prioritize high-risk patients, save lives and augment scarce #radiologists — Insights by Philip Kiracofe, CEO at Startupbootcamp AfriTech . . . . . . . #Healthcare #Radiology #Cancer Medical
The Phase II Trial of Tebentafusp has added a second site: University of Southern California - Norris Cancer Center in Los Angeles, California. For more information, contact Sandy Tran at 323-365-8985 or email her at Sandy.tran@med.usc.edu The Principal Investigator is Mark Agulnik, MD If you believe you may qualify, please speak with your oncologist to determine whether this study is a good fit. The other location is located at Memorial Sloan Kettering Cancer Center, and is being led by Dr. Sandra D'Angelo. For more information, you can contact Dr. D'Angelo at (646) 888-4159 or email SARC045@sarctrials.org. Please note: CCS patients must meet specific eligibility criteria to participate. One critical criterion is being HLA-A*02:01 positive. If you're unsure of your HLA status, your oncologist can order the appropriate test. Learn more here: https://www.clearcellsarcoma.org/research #CCSAwareness #ClearCellSarcoma #Sarcoma #Cancer #RareCancer #PatientSupport #Research #ResearchMatters
The Phase II Trial of Tebentafusp has added a second site: University of Southern California - Norris Cancer Center in Los Angeles, California. For more information, contact Sandy Tran at 323-365-8985 or email her at [email protected] The Principal Investigator is Mark Agulnik, MD If you believe you may qualify, please speak with your oncologist to determine whether this study is a good fit. The other location is located at Memorial Sloan Kettering Cancer Center, and is being led by Dr. Sandra D'Angelo. For more information, you can contact Dr. D'Angelo at (646) 888-4159 or email [email protected]. Please note: CCS patients must meet specific eligibility criteria to participate. One critical criterion is being HLA-A*02:01 positive. If you're unsure of your HLA status, your oncologist can order the appropriate test. Learn more here: https://www.clearcellsarcoma.org/research #CCSAwareness #ClearCellSarcoma #Sarcoma #Cancer #RareCancer #PatientSupport #Research #ResearchMatters
Today, clinical research continues to study new therapies aimed at improving outcomes and quality of life for patients living with urothelial cancer. 💗 If you or a loved one has been diagnosed, learning about clinical trials may help you better understand all available options. 📍Florida 📲 +1 954 225 9361 🔗 Link en bio
Today, clinical research continues to study new therapies aimed at improving outcomes and quality of life for patients living with urothelial cancer. 💗 If you or a loved one has been diagnosed, learning about clinical trials may help you better understand all available options. 📍Florida 📲 +1 954 225 9361 🔗 Link en bio
Did you know AI is now designing cancer treatment? AI is now creating and testing cancer fighting molecules in a fraction of the time it used to take. What once took years in labs can now happen at unprecedented speed. This could change how treatments are discovered and save lives. #AI #Healthcare #CancerResearch #FutureTech #Innovation
Did you know AI is now designing cancer treatment? AI is now creating and testing cancer fighting molecules in a fraction of the time it used to take. What once took years in labs can now happen at unprecedented speed. This could change how treatments are discovered and save lives. #AI #Healthcare #CancerResearch #FutureTech #Innovation
At the Ora Lee Smith Cancer Research Foundation, we aren’t just dreaming of a cure—we are moving beyond hope with our cancer-killing technology, which has already received FDA Breakthrough Device Designation. We are currently fundraising for human trials as a 501(c)(3) nonprofit, and our goal is simple: ensure this treatment is affordable and accessible to everyone, but we can’t get to clinical trials without a dedicated team behind the scenes. We are looking for “difference makers” and a “dream team” of volunteers whose efforts will directly impact how quickly we can bring this treatment to the people who need it most. We need help with: ✨ Project Management & Admin ✨ Public Speaking & Videos ✨ Writing & Graphics ✨ Zoom Tech & Ops Help us keep cancer treatment affordable and accessible for all. 🔗 Join the mission: Link in the first comment below! (Please tag someone who might be a great fit or repost to help us spread the word!) #CancerResearch #cancer #Innovation #volunteer #VolunteerOpportunity HealthTech NonProfit projectmanager leader leadership
At the Ora Lee Smith Cancer Research Foundation, we aren’t just dreaming of a cure—we are moving beyond hope with our cancer-killing technology, which has already received FDA Breakthrough Device Designation. We are currently fundraising for human trials as a 501(c)(3) nonprofit, and our goal is simple: ensure this treatment is affordable and accessible to everyone, but we can’t get to clinical trials without a dedicated team behind the scenes. We are looking for “difference makers” and a “dream team” of volunteers whose efforts will directly impact how quickly we can bring this treatment to the people who need it most. We need help with: ✨ Project Management & Admin ✨ Public Speaking & Videos ✨ Writing & Graphics ✨ Zoom Tech & Ops Help us keep cancer treatment affordable and accessible for all. 🔗 Join the mission: Link in the first comment below! (Please tag someone who might be a great fit or repost to help us spread the word!) #CancerResearch #cancer #Innovation #volunteer #VolunteerOpportunity HealthTech NonProfit projectmanager leader leadership
🧠“Delta Tissue: Platforms for Predicting Tissue State Changes“ is a global @wellcomeleap initiative bringing together experts to develop new ways to profile tissue states and predict how they evolve. ⠀⠀⠀⠀⠀⠀⠀⠀⠀⠀ 🔬As part of this project, #WyssGeneva, @institutcerveau (Nicolas Renier) and @hug_ge (Valérie Dutoit) developed a novel approach to uncover new insights into brain tumor tissue. Over the past years, the team tested and refined multiple protocols to process and analyze glioblastoma samples — one of the most aggressive forms of brain cancer. ⠀⠀⠀⠀⠀⠀⠀⠀⠀⠀ 🤝The result: an exceptionally rich collection of human glioblastoma data, set to be shared with the scientific community to accelerate research and unlock new discoveries.
🧠“Delta Tissue: Platforms for Predicting Tissue State Changes“ is a global @wellcomeleap initiative bringing together experts to develop new ways to profile tissue states and predict how they evolve. ⠀⠀⠀⠀⠀⠀⠀⠀⠀⠀ 🔬As part of this project, #WyssGeneva, @institutcerveau (Nicolas Renier) and @hug_ge (Valérie Dutoit) developed a novel approach to uncover new insights into brain tumor tissue. Over the past years, the team tested and refined multiple protocols to process and analyze glioblastoma samples — one of the most aggressive forms of brain cancer. ⠀⠀⠀⠀⠀⠀⠀⠀⠀⠀ 🤝The result: an exceptionally rich collection of human glioblastoma data, set to be shared with the scientific community to accelerate research and unlock new discoveries.
Your research depends on access to the right support. Share your insights in the EHA Community Survey and help shape what comes next for research funding, training, and opportunities in hematology, in just 10 minutes. Complete the survey for a chance to win a complimentary #EHA2026 registration: link in bio
Your research depends on access to the right support. Share your insights in the EHA Community Survey and help shape what comes next for research funding, training, and opportunities in hematology, in just 10 minutes. Complete the survey for a chance to win a complimentary #EHA2026 registration: link in bio
There always seems to be a huge promise being made on AI solving many of of medical problems we face, with cancer being the main one pointed at. Let’s discuss, with the help of a Harvard doctor, why that is a massive overpromise right now. But also how AI is most definitely going to help us take a step in the right direction in curing diseases. This video was made with the support of the Future of Life Institute! Follow for more AI content!
There always seems to be a huge promise being made on AI solving many of of medical problems we face, with cancer being the main one pointed at. Let’s discuss, with the help of a Harvard doctor, why that is a massive overpromise right now. But also how AI is most definitely going to help us take a step in the right direction in curing diseases. This video was made with the support of the Future of Life Institute! Follow for more AI content!
back to up